Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis

European Journal of Neurology

Volumn 17, Issue 2, 2010, Pages 335-338

  Garcia Martin E ^a   Martinez C ^a   Benito Leon J ^b   Calleja, P ^b   Diaz Sanchez M ^b   Pisa, D ^c   Alonso Navarro, H ^d,e   Ayuso Peralta, L ^d   Torrecilla, D ^d   Agundez J A G ^a   Jimenez Jimenez F J ^d,f  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

^e La Mancha Centro General Hospital   (Spain)

^f Uro Ginecológico   (Spain)

Author keywords

Genetic polymorphisms; Histamine N methyl transferase; Multiple sclerosis; Risk factors

Indexed keywords

HISTAMINE METHYLTRANSFERASE; THREONINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 2Q; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENDER; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; ALLELES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTAMINE N-METHYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SEX FACTORS; SPAIN;

EID: 74549115212     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02720.x     Document Type: Article

References (21)

1. Giordano M, D'Alfonso S, Momigliano-Richiardi P. Genetics of multiple sclerosis: linkage and association studies. Am J Pharmacogenomics 2002 2 : 37 58.
2. Pugliatti M, Harbo HF, Holmøy T, et al. Environmental risk factors in multiple sclerosis. Acta Neurol Scand 2008 188 (Suppl 34 40.
3. Huang JF, Thurmond RL. The new biology of histamine receptors. Curr Allergy Asthma Rep 2008 8 : 21 27.
4. Watanabe T, Taguchi Y, Shiosaka S, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984 295 : 13 25.
5. Obata T. Semicarbazide-sensitive amine oxidase (SSAO) in the brain. Neurochem Res 2002 27 : 263 268.
6. Preuss CV, Wood TC, Szumlanski CL, et al. Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphism that alter activity. Mol Pharmacol 1998 53 : 708 717.
7. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001 50 : 121 127.
8. Agúndez JAG, Luengo A, Herráez O, et al. Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease. Neuromolecular Med 2008 10 : 10 16.
9. Tuomisto L, Kilpeläinen H, Riekkinen P. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 1983 13 : 255 257.
10. Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 1995 37 : 63 66.
11. Zeinstra E, teRiele P, Langlois X, Wilczak N, Leysen J, de Keyser J. Aminergic receptors in astrogliotic plaques from patients with multiple sclerosis. Neurosci Lett 2002 331 : 87 90.
12. Merrill JE, Mohlstrom C. Regulation of antibody-dependent cellular cytotoxicity in multiple sclerosis by central nervous system hormones. Int Arch Allergy Appl Immunol 1987 82 : 195 201.
13. Pedotti R, DeVoss JJ, Youssef S, et al. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc Natl Acad Sci USA 2003 100 : 1867 1872.
14. Dimitriadou V, Pang X, Theoharides TC. Hydroxyzine inhibits experimental allergic encephalomyelitis(EAE) and associated brain mast cell activation. Int J Immunopharmacol 2000 22 : 673 684.
15. Emerson MR, Orentas DM, Lynch SG, LeVine SM. Activation of histamine H2 receptors ameliorates experimental allergic encephalomyelitis. Neuroreport 2002 13 : 1407 1410.
16. Musio S, Gallo B, Scabeni S, et al. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J Immunol 2006 176 : 17 26.
17. Teuscher C, Subramanian M, Noubade R, et al. Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS. Proc Natl Acad Sci USA 2007 104 : 10146 10151.
18. Gillson G, Wright JV, DeLack E, Ballasiotes G. Transdermal histamine in multiple sclerosis, part one: clinical experience. Altern Med Rev 1999 4 : 424 428.
19. Logothetis L, Mylonas IA, Baloyannis S, et al. A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. Int J Immunopathol Pharmacol 2005 18 : 771 778.
20. Alonso A, Jick SS, Hernán MA. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 2006 66 : 572 575.
21. Ollendorf DA, Castelli-Haley J, Oleen-Burkey M. Impact of co-prescribed glatiramer acetate and antihistamine therapy on the likelihood of relapse among patients with multiple sclerosis. J Neurosci Nurs 2008 40 : 281 290.